Clinical Trial: A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-Severe Ulcerative Colitis

U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758101) titled 'A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-Severe Ulcerative Colitis' on July 30.

Brief Summary: This Phase I first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SHR-7590 via subcutaneous or intravenous administration in Chinese healthy participants and patients with moderate-to-severe ulcerative colitis.

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Moderate to Severe Ulcerative Colitis

Intervention: DRUG: SHR-7590

SHR-7590

DRUG: Placebo

Placebo

Recruitment Status: NOT_YET_RECRUITING

Sp...